Lupin and Sandoz Launch Rymti  (Biosimilar, Enbrel) in Canada to Treat Plaque Psoriasis

   Shots:  Followed by HC’s approval in Aug 2022, Lupin with its partner Sandoz launched Rymti (biosimilar, Enbrel) in Canada  The study showed that Rymti has equivalent safety and efficacy to Enbrel. It is a solution for injection in the form of a pre-filled pen & pre-filled syringe  Rymti is intended to treat children and…